Table 1.
Type of Salvage Treatment by the Type of Primary Treatment (N=85)
| Salvage treatment | All (N=85) | Primary treatment | |
|---|---|---|---|
| CCRT (n=39) | CCRT/ACT (n=46) | ||
| Chemotherapy | 29 (34.1) | 15 (17.6) | 14 (16.5) |
| Combination drugb | 27 (31.8) | 15 (17.6) | 12 (14.1) |
| Carboplatin or gemcitabine | 2 (2.4) | - | 2 (2.4) |
| Radiation therapy | 8 (9.4) | 3 (3.5) | 5 (5.9) |
| Extra-pelvic lymph nodea | 3 (3.6) | 2 (2.4) | 1 (1.2) |
| Pelvis (cervix) | 2 (2.4) | - | 2 (2.4) |
| Bone | 3 (3.6) | 1 (1.2) | 2 (2.4) |
| Combined treatment | 18 (21.3) | 11 (13) | 7 (8.3) |
| Chemotherapy + radiation to para-aortic node (n=11) or bone (n=1) | 12 (14.1) | 8 (9.4) | 4 (4.7) |
| Spine or cecum resection + chemotherapy | 2 (2.4) | 1 (1.2) | 1 (1.2) |
| Spine surgery (n=2) or vulva surgery (n=1) + radiation | 3 (3.6) | 2 (2.4) | 1 (1.2) |
| Spine surgery then radiation and chemotherapy | 1 (1.2) | - | 1 (1.2) |
| Surgery (radical hysterectomy) | 2 (2.4) | 1 (1.2) | 1 (1.2) |
| Supportive care | 9 (10.6) | 4 (4.7) | 5 (5.9) |
| Unknown | 19 (22.4) | 5 (5.9) | 14 (16.5) |
aExtra-pelvic lymph nodes included para-aortic (n=3), supraclavicular (n=1) or para-aortic/supraclavicular (n=1); bCombination drug included paclitaxel/carboplatin (n=14), cisplatin/ 5-Fluorouracil (n=11), and cisplatin/ paclitaxel (n=2)